###begin article-title 0
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals
###end article-title 0
###begin p 1
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 859 860 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1002 1003 1002 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1050 1053 1050 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 1183 1186 1183 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 1364 1365 1364 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1499 1503 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 1523 1524 1523 1524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 192 197 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 208 213 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 472 477 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1384 1389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1536 1541 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1581 1586 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1674 1679 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 (Apobec3) antiretroviral factors cause hypermutation of proviral DNA leading to degradation or replication-incompetent HIV-1. However, HIV-1 viral infectivity factor (Vif) suppresses Apobec3 activity through the Cullin 5-Elongin B-Elongin C E3 ubiquitin ligase complex. We examined the effect of genetic polymorphisms in the CUL5 gene (encoding Cullin 5 protein) on AIDS disease progression in five HIV-1 longitudinal cohorts. A total of 12 single nucleotide polymorphisms (SNPs) spanning 93 kb in the CUL5 locus were genotyped and their haplotypes inferred. A phylogenetic network analysis revealed that CUL5 haplotypes were grouped into two clusters of evolutionarily related haplotypes. Cox survival analysis and mixed effects models were used to assess time to AIDS outcomes and CD4+ T cell trajectories, respectively. Relative to cluster I haplotypes, the collective cluster II haplotypes were associated with more rapid CD4+ T cell loss (relative hazards [RH] = 1.47 and p = 0.009), in a dose-dependent fashion. This effect was mainly attributable to a single cluster II haplotype (Hap10) (RH = 2.49 and p = 0.00001), possibly due to differential nuclear protein-binding efficiencies of a Hap10-specifying SNP as indicated by a gel shift assay. Consistent effects were observed for CD4+ T cell counts and HIV-1 viral load trajectories over time. The findings of both functional and genetic epidemiologic consequences of CUL5 polymorphism on CD4+ T cell and HIV-1 levels point to a role for Cullin 5 in HIV-1 pathogenesis and suggest interference with the Vif-Cullin 5 pathway as a possible anti-HIV-1 therapeutic strategy.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin p 3
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 804 805 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 998 999 998 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 131 134 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 202 207 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 231 236 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 302 307 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 649 654 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 693 698 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 821 829 <span type="species:ncbi:9606">patients</span>
###xml 844 849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1216 1221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1284 1289 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 G (Apobec3G) is an innate antiviral protein that inhibits HIV type 1 (HIV-1) replication by causing deleterious mutations in the HIV-1 genome. Unfortunately, HIV-1 has a strategy to defeat the antiviral activity of Apobec3G. The HIV-1 viral infectivity factor (Vif) binds to Apobec3G leading to the degradation of Apobec3G through a complex containing Cullin 5 and the proteins Elongin B and Elongin C. Since Cullin 5 directly interacts with Vif and is critical to the Apobec3G degradation pathway, the authors asked if genetic variation of CUL5 could tip the balance between HIV-1 and Apobec3G and modify the course of HIV-1 infection. They showed that genetic variation in the CUL5 gene encoding Cullin 5 affected the rate of CD4+ T cell loss in patients infected with HIV-1. CUL5 haplotypes formed two clusters of evolutionarily related haplotypes with opposing effects-cluster I delayed and the cluster II accelerated CD4+ T cell loss. The effect was mainly attributable to a single haplotype or its tagging-SNP, which demonstrated differential binding of transcription factors. This finding highlights the epidemiologic importance of the HIV-1 and Cullin 5 interaction and suggests that the factors in the HIV-1 Vif-Apobec3G degradation pathway may be targets for antiviral drugs.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b001">1</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b002">2</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b003">3</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b008">8</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b011">11</xref>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b005">5</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b012">12</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b013">13</xref>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 1242 1243 1242 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b014">14</xref>
###xml 1419 1420 1419 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 1421 1423 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b014">14</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b015">15</xref>
###xml 1567 1569 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b016">16</xref>
###xml 1707 1709 1707 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b016">16</xref>
###xml 1836 1838 1836 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b017">17</xref>
###xml 147 152 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 186 191 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 269 274 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 676 681 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 876 881 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1283 1288 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1533 1538 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Members of the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 (Apobec3) family of cytidine deaminases are innate cellular anti-HIV-1 factors [1,2]. In the absence of HIV-1 viral infectivity factor (Vif), both Apobec3G and Apobec3F are packaged into HIV-1 virions and during reverse transcription in the newly infected cell deaminate dC to dU in the nascent minus-strand DNA. This deamination results in either the degradation of the cDNA through a cellular uracil-DNA-glycosidase degradation pathway or pervasive G to A hypermutation in the plus-strand proviral cDNA [3-7]. However, the antiretroviral activities of Apobec3G and Apobec3F are suppressed by HIV-1 Vif, effectively preventing incorporation of Apobec3G or Apobec3F into virions, primarily by inducing Apobec3G degradation by proteasomes [8-11], and perhaps by additional mechanisms [5,12,13]. HIV-1 Vif interacts with the cellular proteins Cullin 5, Elongin B , Elongin C, and Rbx1 to form an E3 ubiquitin ligase complex that induces polyubiquitination and proteasomal degradation [7]. When the Cullin 5 complex is inhibited by mutating Cullin 5 or is down-regulated by RNA interference, Vif-induced polyubiquitination and degradation of Apobec3G is blocked [7,14]. This suggests that the ability of HIV-1 Vif to suppress the antiviral activity of the two Apobec3 proteins specifically depends on Cullin 5-Elongin B-Elongin C function [7,14]. Most recently, the Vif-Cullin 5 binding domain has been mapped to a highly conserved HCCH motif within the HIV-1 Vif zinc-binding domain [15,16]. The region in Cullin 5 that mediates Vif interaction has been mapped to the loop region between helices 6 and 7 (amino acids 120-138) [16]. In an independent report, the Vif interaction region was mapped to the first cullin repeat (amino acids 1-158) of Cullin 5 [17].
###end p 5
###begin p 6
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b018">18</xref>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 243 248 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 364 369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We recently reported that a nonsynonymous single nucleotide polymorphism (SNP) in the APOBEC3G gene may be associated with altered AIDS progression [18]. Since Cullin 5 is a critical host factor in the Vif-mediated degradation pathway of anti-HIV-1 proteins Apobec3G and Apobec3F, we investigated the effects of genetic variation in CUL5 on the natural history of HIV-1 progression.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Description of CUL5 Variants
###end title 8
###begin p 9
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 74 82 74 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">Figure 1</xref>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL</italic>
###xml 629 637 629 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">Figure 1</xref>
###xml 642 650 642 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st001">Table S1</xref>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 150 155 <span type="species:ncbi:9606">human</span>
The CUL5 gene is approximately 100 kb in length and consists of 19 exons (Figure 1). At the start of this project, about 40 SNPs for the CUL5 gene on human Chromosome 11q22 had been deposited in the National Center for Biotechnology Information database SNP (NCBI dbSNP) (). No nonsynonymous nucleotide replacements have been reported to date. Through resequencing of 188 DNA samples, we did not discover any additional SNPs in exons 15-19 in the C terminus of the CUL5 gene or in the putative promoter region. By considering SNP location, spacing, and allele frequency, 12 SNPs were selected for genotyping in the AIDS cohorts (Figure 1 and Table S1). Of these 12 SNPs, one SNP (SNP5, rs7117111) is within the coding region, one (SNP12) is in the 3' UTR, and the remaining SNPs are in introns. SNP5 is a synonymous transition (CAA > CAG) at the third position of codon 75 encoding glutamine (Q). Each of the 12 SNPs was in Hardy-Weinberg equilibrium (p > 0.05) in African Americans (AA) and European Americans (EA).
###end p 9
###begin title 10
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 38 43 <span type="species:ncbi:9606">Human</span>
Gene Map, SNPs, and Haplotypes in the Human CUL5 Gene
###end title 10
###begin p 11
Coding exons are marked by black blocks, and 5' and 3' UTR by white blocks. Nucleotide changes and frequencies of SNPs and haplotypes (Hap) in AA, EA, and HC are presented. ctSNPs are shown in color.
###end p 11
###begin title 12
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
CUL5 SNPs Exhibit Strong Linkage Disequilibrium
###end title 12
###begin p 13
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 41 49 41 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">Figure 2</xref>
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">2</xref>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 200 208 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">Figure 2</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">2</xref>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b019">19</xref>
###xml 1098 1101 1098 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL</italic>
The 12 SNPs span 93 kb of the CUL5 gene (Figure 2A and 2B). The extent of linkage disequilibrium (LD) was assessed by calculating all pairwise D' values among the CUL5 SNPs, separately for AA and EA (Figure 2A and 2B). Strong LD was observed among all SNPs (D' range 0.92-1.0) in EA and almost all SNPs in AA, with the majority of marker pairs showing D' values between 0.95 and 1.0. In both AA and EA, as well as in a Han Chinese (HC) population, SNPs 3, 5, and 8 and SNPs 7 and 9 were in perfect LD (D' = 1 and r2 = 1). Thus each SNP carries the same information content as its proxies. We therefore used SNP5 as a proxy for SNPs 3 and 8 and SNP7 as a proxy for SNP9. SNP5 has a diverse allele distribution in different population groups: the A allele frequency is 0.61, 0.34, and 0.13 in AA, EA, and HC, respectively. Only a single LD block formed by all 12 SNPs was identified for both population groups as defined by confidence intervals of pairwise D' between all SNPs [19]. Additional data from the International HapMap Genome Browser () showed that this LD block does not extend beyond the CUL5 gene region (unpublished data).
###end p 13
###begin title 14
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
LD of CUL5 SNPs in AA and EA
###end title 14
###begin p 15
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 1243 1250 1243 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 644 654 <span type="species:ncbi:9598">chimpanzee</span>
LD of CUL5 SNPs is shown in AA (A) and EA (B). Pairwise D' plots were generated using Haploview with its standard color scheme. Dark-red squares indicate high D' values, light-blue squares indicate high D' values with low LOD scores, and light-red and white squares indicate low D' values. D' values were indicated for those not equal to 1.0. A single LD block was defined for both AA and EA under the default confidence interval criteria. A reduced-medium network for the genealogical relationship of CUL5 haplotypes is shown in AA (C) and EA (D). The network was inferred in terms of mutational distance, on the basis of 12 CUL5 SNPs and one chimpanzee (Chimp) sequence. Median vector (mv1), the consensus sequences inferred by parsimony criteria, represents possible unsampled sequences or extinct ancestral sequences. Haplotypes (H1-H11) are represented by circles, whose area reflects the number of alleles observed in each population. The solid branches between haplotypes represent mutational events or SNPs (S1-S12). The circles in green show haplotypes with detrimental effect and those in blue show protective effect on AIDS progression in the Cox model analysis; the protective effect of H3 in light blue was of less certainty (see Results). The haplotypes were separated into two clusters, cluster I and II, carrying ctSNP5 A or G, respectively. Cluster I and II in AA are shaded in blue and green, respectively. SNP2 is omitted in (B) and (D) as it was absent in EA.
###end p 15
###begin p 16
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">Figure 1</xref>
There were 11 haplotypes observed in total in the three populations: six (1, 2, 3, 7, 8, and 10) haplotypes were shared among all racial groups, while five haplotypes were observed only in AA (Figure 1). In EA, six major haplotypes with frequencies between 0.07 and 0.43 represented 98.8% of all chromosomes. In AA, 11 haplotypes with frequencies between 0.03 and 0.21 represent 95.5% of all chromosomes, eight of which had a frequency below 10%. The haplotype distribution in HC closely resembled that of EA.
###end p 16
###begin title 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
CUL5 Haplotypes Form Two Clusters Separated by Three Cluster-Tagging SNPs
###end title 17
###begin p 18
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b020">20</xref>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">Figure 2</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">2</xref>
###xml 930 939 930 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">Figures 1</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">2</xref>
###xml 949 950 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">2</xref>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 362 372 <span type="species:ncbi:9598">chimpanzee</span>
To determine the evolutionarily relatedness of the haplotypes, an evolutionary tree of the CUL5 haplotypes composed of 12 SNPs was reconstructed using the phylogenetic network method [20] (Figure 2C and 2D). The network comprised two main clusters (referred to here as cluster I and II), which differ at SNPs 3, 5, and 8 in the human. These are separated by the chimpanzee sequence representing the ancestral haplotype and the median vector representing possibly extant unsampled sequences or extinct ancestral sequences. Since the proxy SNPs 3, 5, and 8 separated and defined clusters I and II, we defined these as cluster-tagging (ct) SNPs (ctSNPs). Cluster I and II contain six and five haplotypes, respectively. All haplotypes in cluster I contain the ancestral alleles at SNP 3, 5, and 8 (G, A, and A, respectively), and all haplotypes in cluster II contain the derived allele at SNP 3, 5, and 8 (A, G, and G, respectively) (Figures 1, 2C, and 2D).
###end p 18
###begin title 19
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effect of CUL5 SNPs and Haplotypes on Susceptibility to HIV-1 Infection
###end title 19
###begin p 20
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 121 126 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 161 166 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We compared the CUL5 SNP allele and haplotype frequency distributions among highly exposed but uninfected individuals to HIV-1 seronegative individuals (SN) and HIV-1-infected seroconverter individuals (SC). No distortion of frequency distribution between risk groups was observed for any SNP or haplotype in AA or EA (unpublished data), suggesting that the CUL5 genetic variation assessed herein has no obvious effect on susceptibility to HIV-1 infection.
###end p 20
###begin title 21
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CUL5 Clusters Were Associated with CD4+ T Cell Depletion in African Americans
###end title 21
###begin p 22
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 703 710 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t001">Table 1</xref>
###xml 848 849 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 878 881 878 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adj</sub>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 959 966 959 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t001">Table 1</xref>
###xml 1159 1160 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1168 1171 1168 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 1190 1198 1190 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g003">Figure 3</xref>
###xml 1324 1325 1324 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1520 1528 1520 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g003">Figure 3</xref>
AA and EA were analyzed separately since the allele frequencies and haplotype structures differed between the two groups. To minimize the haplotypes and SNPs to be tested, we took advantage of the unique haplotype relationship in CUL5 revealed in the haplotype network. We first tested the hypothesis that the two major clusters of haplotypes were differentially associated with disease progression in AA and EA. Cluster II identified by the ctSNP 5 G allele was significantly associated with accelerated rates of progression to CD4+ < 200 in both the unadjusted analysis and after adjusting (adj) for the confounding effects of HLA B57 and HLA homozygosity in the Cox proportional hazards model in AA (Table 1). When an additive genetic effect was tested in the Cox model analysis, the G allele significantly influenced the risk of dropping to CD4+ < 200 (relative hazards [RH]adj = 1.47 and p = 0.009). No significant associations were found for AIDS-1987 (Table 1). Kaplan-Meier survival curves stratified for the ctSNP5 A/A, A/G, and G/G genotypes suggested an additive effect of the G allele (and by inference cluster II haplotypes) on progression to CD4+ < 200 (p = 0.003, log-rank) (Figure 3A). These results suggest that cluster II haplotypes, all of which carry ctSNP5 G, were associated with more rapid loss of CD4+ T cells, and that this effect is dose-dependent: individuals bearing one or two haplotypes from cluster II are at greater risk relative to individuals bearing any two haplotypes from cluster 1 (Figure 3A).
###end p 22
###begin p 23
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL</italic>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Effects of CUL5 SNPs on Progression to CD4+ T Cells < 200 and AIDS in African Americans
###end p 23
###begin title 24
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Kaplan-Meier Survival Analysis of CUL5 Variants on Progression from Seroconversion to CD4+ T cells < 200 /mm3 in AA
###end title 24
###begin p 25
(A) Shows ctSNP5 (the cluster); (B) shows htSNP6 (Hap10); and (C) shows compound genotypes of ctSNP5 and htSNP6.
###end p 25
###begin title 26
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
CUL5 Cluster I and II Contain Protective and Detrimental Haplotypes, Respectively
###end title 26
###begin p 27
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 241 242 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 266 251 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adj</sub>
###xml 278 281 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 316 324 304 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g003">Figure 3</xref>
###xml 330 337 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t001">Table 1</xref>
###xml 418 419 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 476 477 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 573 574 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 618 621 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 643 646 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 665 673 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g003">Figure 3</xref>
We next examined the role of each haplotype to identify specific high-risk haplotypes. The Cox model analysis indicated that the haplotype-tagging (ht)SNP6 G allele carried only on Hap10 ( f approximately 5%) was a strong risk factor for CD4+ T cell depletion (RHadj = 2.49 and p = 0.00001, for the additive model) (Figure 3B and Table 1). In a Kaplan-Meier survival plot, the htSNP6 G allele was a risk factor for CD4+ < 200: the three GG homozygous individuals developed CD4+ < 200 within five years (and all died within six years), and all A/G heterozgotes developed CD4+ < 200 within nine years of seroconversion (p = 0.0003, log-rank and p = 0.008, Wilcoxon) (Figure 3B).
###end p 27
###begin p 28
###xml 188 191 188 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adj</sub>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 445 448 445 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adj</sub>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 524 525 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 604 612 604 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g003">Figure 3</xref>
###xml 792 795 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Because Hap10 carries both the htSNP6 G allele and the ctSNP5 G allele, we tested ctSNP5 adjusting for the effects of htSNP6 within a Cox model. The ctSNP5 effect became nonsignificant (RHadj = 1.25 and p = 0.170), suggesting that most of the association of ctSNP5 G allele and other cluster II haplotypes with CD4+ T cell loss was due to htSNP6. When considering ctSNP5 as a confounding covariate, the association remained robust for htSNP6 (RHadj = 2.16 and p = 0.0009). However, not all of the ctSNP5 association with CD4+ T cell decline could be attributed to htSNP6. This can be readily observed in Figure 3C where individuals homozygous for cluster I haplotypes (ctSNP5 A/A) are protective relative to cluster II carriers, and the greatest risk is for carriers of the cluster II Hap10 (p = 0.0002, log-rank). This suggests that one or more ctSNP5 G-bearing haplotypes and the htSNP6 G-bearing Hap10 may be tracking the same functional allele elsewhere in the CUL5 gene.
###end p 28
###begin p 29
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t002">Table 2</xref>
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st002">Table S2</xref>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t001">Table 1</xref>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st002">Table S2</xref>
Hap1 and Hap6 in cluster I also were associated with delayed time to CD4+ < 200 (RH = 0.59, 0.41; p = 0.013, 0.02, respectively) (Table 2 and Table S2). None of the SNPs or haplotypes was significantly associated with progression to the AIDS late-stage endpoint AIDS-87 (Table 1 and Table S2).
###end p 29
###begin p 30
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Effects of Selected CUL5 Haplotypes on AIDS Progression in AA by Cox Model Analysis
###end p 30
###begin title 31
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL</italic>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Relative Contribution of CUL5 Haplotypes on CD4+ T Cell Depletion
###end title 31
###begin p 32
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st003">Table S3</xref>
To evaluate the relative contributions of the protective Hap1 and Hap6 haplotypes and the accelerating Hap10 on time to CD4+ < 200, the Akaike Information Criteria (AIC) were used to select the best Cox proportional hazards model. The covariates HLA homozygosity and HLA B57 were used in the base mode (model 1). The smallest AIC was achieved for model 5 where all three haplotypes were added in model 5 (Table S3).
###end p 32
###begin title 33
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Role of CUL5 SNPs and Haplotypes on AIDS-Free Survival in European Americans
###end title 33
###begin p 34
###xml 49 57 49 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g002">Figure 2</xref>
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st004">Table S4</xref>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 475 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st002">Table S2</xref>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 714 717 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 725 733 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st004">Table S4</xref>
The six haplotypes in EA also form two clusters (Figure 2D). In the Cox model analysis, ctSNP5 showed no significant associations (Table S4), although weak associations were observed for two haplotypes and three SNPs. The cluster I haplotype Hap3 had an additive protective effect on rate of progression to CD4+ < 200 and AIDS 1993 (RH = 0.71-0.68 per allele, p = 0.026-0.006, respectively), and the cluster I Hap7 had a slight accelerating effect (CD4+ < 200, RH = 1.25, p = 0.056; AIDS-93, RH = 1.31, p = 0.010, respectively) (Table S2). Small effects were also observed for SNP4 (protective for AIDS-93, RH = 0.78, p = 0.03), SNP7 (risk for AIDS-93, RH = 1.24, p = 0.02), and SNP12 (risk for AIDS-93, RH = 1.2, p = 0.02) (Table S4).
###end p 34
###begin title 35
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effect of CUL5 SNPs and Haplotypes on Longitudinal CD4+ T Cell Counts and HIV-1 RNA Levels in African Americans from the AIDS Link to the Intravenous Experience Cohort
###end title 35
###begin p 36
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 156 168 <span type="species:ncbi:9606">participants</span>
###xml 265 272 <span type="species:ncbi:9606">patient</span>
###xml 516 521 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD4+ T cell counts and HIV-1 RNA levels were measured multiple times during the follow-up period for the AIDS Link to the Intravenous Experience (ALIVE) SC participants. An average of 7.8 and 6.8 measurements of CD4+ T cell counts and viral load, respectively, per patient for up to nine years from the seroconversion to 1997-censoring date were available for analysis. We evaluated the effects of ctSNP5 (representing all cluster II haplotypes) and htSNP6 (Hap10) on the longitudinal slope of CD4+ T cell count and HIV-1 RNA level over the clinical course using the linear mixed random effects model.
###end p 36
###begin p 37
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 116 124 116 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g004">Figure 4</xref>
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
###xml 199 201 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p=</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&#8201;=</italic>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 432 439 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 600 603 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 620 623 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 765 772 765 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
The ctSNP5 G allele tends to be associated with gradient differences for CD4+ T cell slopes stratified by genotype (Figure 4 and Table 3): each copy of the ctSNP5 G allele was associated with -0.99 (p= 0.05) or -1.23 (p = 0.01) lower mean CD4+ T cell trajectory, over the observation periods from seroconversion to July 31, 1997 (date censored before highly active antiretroviral therapy [HAART]) or to July 31, 2004, respectively (Table 3). The htSNP6 G allele on Hap10 was strongly associated with a more rapid mean loss of CD4+ T cells: each copy of the ctSNP6 G allele was associated with -2.56 (p = 0.01) or -2.63 (p = 0.01) lower mean CD4+ T cell trajectory, for the observation periods from seroconversion to July 31, 1997 or to July 31, 2004, respectively (Table 3).
###end p 37
###begin title 38
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Arithmetic Mean of CD4+ T Cell Counts over Time in the ALIVE Cohort by ctSNP5 (the Cluster)
###end title 38
###begin p 39
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The observation period was from seroconversion to the censoring date of July 31, 1997. CD4+ T cell counts were measured at 6-month intervals and were square-root transformed with standard error represented by the vertical bar.
###end p 39
###begin p 40
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effects of CUL5 and APOBEC3G SNPs on the Longitudinal CD4+ T cell and HIV-1 RNA Slope Gradients in the ALIVE Cohort
###end p 40
###begin p 41
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 269 276 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 235 240 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For HIV-1 RNA level, a modest increase in HIV-1 RNA levels was observed for ctSNP5 under an additive model (+0.18, p = 0.04). No effect was detected for SNP6, possibly due to the low frequency of the minor allele and smaller number of HIV-1 RNA measurements available (Table 3).
###end p 41
###begin title 42
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Interactions between APOBEC3G-H186R and CUL5 SNPs
###end title 42
###begin p 43
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b018">18</xref>
###xml 288 296 288 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 476 483 476 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
###xml 541 549 541 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 606 609 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 721 724 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 742 745 742 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">Table 3</xref>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because Cullin 5 affects Apobec3G's anti-HIV-1 activity, we reasoned that the CUL5 cluster II haplotypes may interact with the APOBEC3G-186R allele, previously reported by us to be associated with accelerated CD4+ T cell depletion [18]. Using the group of individuals homozygous for both APOBEC3G-186H and cluster I haplotypes as a reference group, we tested the effects of different combinations of alleles on the mean CD4+ T cell trajectories using the mixed effects model (Table 3). We observed a significant additive interaction between APOBEC3G-186R carriers and ctSNP5 G or htSNP6 G carriers (-2.88, p = 0.01 and -3.64, p = 0.02, respectively), in the data censored in July 31, 1997. A stronger association (-3.11, p = 0.005 and -4.16, p = 0.007, respectively) was obtained using the extended followed-up time to July 31, 2004 (Table 3).
###end p 43
###begin title 44
Estimate of the False Discovery Rates
###end title 44
###begin p 45
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 442 443 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 458 459 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 527 528 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 606 607 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 615 623 613 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t001">Tables 1</xref>
###xml 624 625 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030019-t003">3</xref>
###xml 630 639 628 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st002">Tables S2</xref>
###xml 640 642 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st004">S4</xref>
To account for the multiple comparisons made in this study, we estimated the q-value statistic to estimate the false discovery rate (FDR). The FDR was calculated incorporating all p-values from 122 tests performed for SNPs and haplotypes in the Cox model and mixed effects model. The q-value was obtained for each and all of the p-values, and the q-values for those with p </= 0.05 were presented. The associations for ctSNP5, htSNP6 with CD4+ < 200, and CD4+ T cell slope in AA as well as Hap1, Hap7 in AA, and Hap3 in EA had q-values below the stringent cutoff of 0.05 indicating a FDR of 5% for a given p-value (Tables 1-3 and Tables S2-S4).
###end p 45
###begin title 46
Electrophoretic Mobility-Shift Assay
###end title 46
###begin p 47
###xml 495 503 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g005">Figure 5</xref>
###xml 184 189 <span type="species:ncbi:9606">human</span>
To explore the possibility that the SNP6 may differentially bind to nuclear proteins, probes containing the SNP6 A allele or the G allele were incubated with the nuclear extracts from human T lymphocytes stimulated with interleukin (IL)-4 in an electrophoretic mobility-shift assay (EMSA). A 1.85-fold or 1.75-fold increase in the band density was observed for the SNP6 G allele in comparison with the common A allele from two independent experiments, although no pattern changes were observed (Figure 5). A similar but weaker result was obtained in the IL-2 stimulated T cells (unpublished data). This suggests that the SNP6 G allele has higher binding affinity with unknown nuclear proteins.
###end p 47
###begin title 48
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
EMSA Analysis of CUL5 SNP6 A/G
###end title 48
###begin p 49
###xml 22 27 <span type="species:ncbi:9606">human</span>
Nuclear extracts from human T lymphocytes induced by IL-4 were bound to the oligonucleotide containing the SNP6 A allele (lane A) or G allele (lane B), without cold competitors. Lane C contained nuclear extracts, SNP6 A allele probe, and a 100-fold excess of its cold probe as competitor. Lane D contained nuclear extracts, SNP6 G allele probe, and a 100-fold excess of its cold probe as competitor. An arrow indicates the band showing differential binding of nuclear factor(s) to the oligonucleotides.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b014">14</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b021">21</xref>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 905 906 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1195 1196 1195 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1259 1263 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 1290 1298 1290 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 1311 1312 1311 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1405 1406 1405 1406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1420 1422 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b018">18</xref>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 374 379 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 454 459 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The ability of Apobec3G to restrict HIV-1 replication through hypermutation is suppressed by HIV-1 Vif binding to CUL5 gene product Cullin 5, leading to the polyubiquitination and degradation of Apobec3G and Apobec3F through the Cullin 5-Elongin B-Elongin C E3 ubiquitin ligase pathway [7,14,21]. To understand the role of genetic variation in the gene encoding Cullin 5 on HIV-1/AIDS, we examined 12 SNPs and their haplotypes on risk and progression of HIV-1 disease. The haplotypes formed two clusters defined by alleles at the proxy SNPs 3, 5, and 8. Relative to cluster I, cluster II haplotypes as a group were associated with faster CD4+ T cell decline as indicated by the Cox model analysis of survival to the endpoint of CD4+ < 200 and reaffirmed by the mixed effects model assessing CD4+ T cell trajectory over time. Individuals who were carriers of any two cluster II haplotypes progressed to CD4+ < 200 about 5.7 years faster than those who carried any two cluster I haplotypes. The effect of cluster II was largely attributable to Hap10, carrying both ctSNP5 G and htSNP6 G alleles. On the other hand, cluster I contains the two protective haplotypes, Hap1 and Hap6, which delayed CD4+ T cell loss. We also observed an additive interaction between CUL5 cluster II haplotypes and APOBEC3G-H186R on CD4+ T cell slope, suggesting that Apobec3G and Cullin 5 likely confer independent effects on CD4+ T cell loss [18].
###end p 51
###begin p 52
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 195 200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The genetic effects derived from multiple SNPs and haplotypes, and from the haplotype clusters, provide evidence that genetic variation in CUL5 likely modifies the rate of disease progression of HIV-1 with the effects being stronger and more consistent among AA than EA. The differences observed between the two racial groups suggest that there are additional functional alleles in LD with the SNP markers assessed in this study.
###end p 52
###begin p 53
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To assess the possibility that the observed associations were due to the multiple tests, we estimated the FDR for all the tests performed. Although this test is quite conservative as there is considerable correlation among SNPs, haplotypes, and disease endpoints, the FDR for significant (p < 0.05) SNP and haplotype associations in both AA and EA was 5% or less. However, the gold standard for validation of genetic associations remains confirmation in other adequately powered studies.
###end p 53
###begin p 54
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b022">22</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b023">23</xref>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 106 112 <span type="species:ncbi:9986">rabbit</span>
Human Cullin 5 is a highly conserved 780-amino acid protein, differing by only seven amino acids from the rabbit VACM-1 protein [22,23]. The conservation of Cullin 5 amino acid sequence suggests that the Cullin 5 protein is under strong functional constraint and purifying selection. The fact that genetic effects observed for SNP5 and SNP6 were most robust under the additive genetic model suggests a dose-effect of the factors. It is thus most likely that the causal sequence or alleles lie in regulatory elements affecting CUL5 mRNA or protein levels. However, no promoter or nonsynonymous SNPs were reported among over 230 SNPs in the CUL5 gene deposited in the dbSNP database as of July 6, 2006 and none were discovered when resequencing putative promoter and exonic regions in 188 individuals for this study.
###end p 54
###begin p 55
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 961 965 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 1014 1015 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1071 1075 1071 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 1264 1268 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 524 529 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1036 1041 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1086 1091 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1290 1295 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In an in vitro electromobility gel shift assay, the DNA fragment carrying the G allele of SNP6, compared to the more common A allele, was found to show an increased binding affinity to nuclear proteins from human T lymphocytes. This suggests that SNP6 is a functional SNP that may affect the gene regulation or interaction. A higher level of Cullin 5 due to a potential up-regulation of CUL5 gene would enhance the Cullin 5-Vif interaction, leading to stronger inhibition of antiviral protein Apobec3G and, hence, increased HIV-1 infectivity. In addition, a real-time PCR was performed to measure the mRNA expression levels of CUL5 from EBV-transformed B cell lines in three, three, and six normal individuals carrying CUL5 SNP5 genotypes AA, GG, and AG, respectively. No difference greater than 2-fold (minimal detection threshold) was detected between genotypes (unpublished data), though a more subtle difference could not be excluded. Little is known about CUL5 regulation in different cell types or within CD4+ T cells infected by HIV-1. It is possible that SNPs in CUL5 influence HIV-1 disease by alternative splicing, by affecting mRNA stability, or by unknown protein structural change, in addition to altered gene expression. The underlying mechanisms of CUL5 genetic variation on HIV-1 warrant further investigation.
###end p 55
###begin p 56
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b014">14</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b014">14</xref>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 858 859 858 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 206 211 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 537 542 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 934 939 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
This study provides evidence that CUL5 gene variation is associated with modified rates of CD4+ T cell loss. If confirmed, these findings demonstrate the epidemiologic importance of the interaction between HIV-1 Vif and human Cullin 5. The antiviral activity of both Apobec3G and Apobec3F have been shown to have antiviral activity that is fully suppressed by HIV-1 Vif through the Cullin 5 containing E3 ubiquitin ligase [7,14]. Depletion of Cullin 5 through RNA interference or overexpression of Cullin 5 mutants blocks the ability of HIV-1 Vif to suppress both Apobec3G and Apobec3F [14]. It is therefore possible that regulation of expression levels of CUL5 genetic variants may affect the efficiency of Vif-mediated degradation of Apobec3F and Apobec3G. These in vitro studies, together with our findings that CUL5 genetic factors modify the rate of CD4+ T cell loss, provide support for the development of inhibitors that block HIV-1 Vif and Cullin 5-Elongin B-Elongin C E3 ligase complex binding, aiming to limit or prevent degradation of these potent antiviral host factors.
###end p 56
###begin title 57
Materials and Methods
###end title 57
###begin title 58
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants.
###end title 58
###begin p 59
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b024">24</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b025">25</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b026">26</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b027">27</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b028">28</xref>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 305 308 <span type="species:ncbi:9606">men</span>
###xml 327 330 <span type="species:ncbi:9606">men</span>
###xml 521 524 <span type="species:ncbi:9606">men</span>
###xml 543 546 <span type="species:ncbi:9606">men</span>
###xml 727 735 <span type="species:ncbi:9606">children</span>
###xml 772 777 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 946 953 <span type="species:ncbi:9606">persons</span>
###xml 1062 1067 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1153 1165 <span type="species:ncbi:9606">participants</span>
Study participants were enrolled in five United States-based natural history HIV/AIDS cohorts. ALIVE is a community-based cohort of intravenous injection drug users in Baltimore enrolled in 1988-1989 [24], consisting of 92% AA. Multicenter AIDS Cohort Study (MACS) is a longitudinal prospective cohort of men who have sex with men from four U.S. cities: Chicago, Baltimore, Pittsburgh, and Los Angeles enrolled in 1984-1985 [25], consisting of 83% EA and 10% AA. The San Francisco City Clinic Study (SFCC) is a cohort of men who have sex with men originally enrolled in a hepatitis B study in 1978-1980 [26], consisting of 96% EA. Hemophilia Growth and Development Study (HGDS) is a multicenter prospective study that enrolled children with hemophilia who were exposed to HIV-1 through blood products between 1982 and 1983 [27], consisting of 72% EA and 11% AA. The Multicenter Hemophilia Cohort Study (MHCS) is a prospective study that enrolled persons with hemophilia [28], consisting of 90% EA and 6% AA. The individuals genotyped in this report consisted of HIV-1 SC, seroprevalents, SN, and high-risk exposed uninfected (HREU) for a total of 3,476 participants (2,169 EA and 1,307 AA). The numbers of EA and AA individuals studied in each disease category were as follows: SC = 659, 290; SN = 309, 336; HREU = 141, 82; respectively. Of 290 AA SC, 237, 42, five, and five were from ALIVE, MACS, MHCS, and HGDS, respectively.
###end p 59
###begin p 60
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b024">24</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b029">29</xref>
###xml 1139 1143 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The date of seroconversion after study enrollment was estimated as the midpoint between the last seronegative and first seropositive HIV-1 antibody test; only individuals with less than two years' elapsed time between the two tests were included in the seroconverter progression analysis. The censoring date was the earliest of the date of the last recorded visit, or December 31, 1995 for the MACS, MHCS, HGDS, and SFCC, or July 31, 1997 for the ALIVE cohort, to avoid potential confounding by HAART. The censoring date was extended in the ALIVE cohort because of delayed administration of HAART to this group [24,29]. The MACS, MHCS, SFCC, and ALIVE consists of both SC (infected after study enrollment) and seroprevalents (infected before study enrollment) individuals: because of the potential for frailty bias (missing the most rapid progressors to AIDS and death) among seroprevalents, only SC enrolled in the ALIVE, MACS, MHCS, and SFCC were used in the analysis. In addition, DNA samples from 110 normal blood donor HC were included to provide an estimate of allele frequencies in a major Asian population and to inform for future CUL5 genetic studies in this population. This group was not used in the association analyses.
###end p 60
###begin p 61
###xml 130 142 <span type="species:ncbi:9606">participants</span>
The study was approved by the Institutional Review Boards of participating institutes, and informed consent was obtained from the participants.
###end p 61
###begin title 62
Identification of SNPs.
###end title 62
###begin p 63
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b007">7</xref>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">Figure 1</xref>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030019-g001">1</xref>
A panel consisting of 94 DNA samples each from EA and AA was partially resequenced to discover novel CUL5 polymorphisms. PCR primers were designed based on GenBank DNA sequence AP003307 and mRNA sequence NM_003478 to cover the putative promoter region, 5' UTR, exons 15-19 encoding the C terminus that was shown to confer major function [7], and 3' UTR of the CUL5 gene. SNPs were obtained from dbSNP, HapMap (http://www.hapmap.org), and TaqMan SNP Genotyping Assay databases (). A total of 12 SNPs were selected for genotyping by considering SNP location, spacing, and at least 5% allele frequency (Figure 1A and 1B). Haplotype-tagging (ht)SNPs were given preference in the SNP selection.
###end p 63
###begin title 64
Genotyping of SNPs.
###end title 64
###begin p 65
###xml 241 249 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030019-st001">Table S1</xref>
Genotyping was performed using TaqMan assays according to the manufacturer's manual (Applied Biosystems, ). TaqMan primer and probes were designed by using the Primer Express software or by the Assay-by-Demand service of Applied Biosystems (Table S1). A total of eight water controls were included on each plate to monitor the potential PCR contamination, and 10% of SC and HREU samples were genotyped twice. The genotypes obtained were free of water contamination or of inconsistencies between duplicates. SNP5 was genotyped twice using two different sets of primers and probes, and the results were identical.
###end p 65
###begin title 66
Statistical analysis.
###end title 66
###begin p 67
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 703 704 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 862 863 862 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b030">30</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b031">31</xref>
###xml 1558 1560 1558 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 1741 1745 1741 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1755 1757 1751 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b032">32</xref>
###xml 1760 1764 1756 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 1770 1772 1766 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b033">33</xref>
###xml 1775 1779 1771 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1784 1786 1780 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b034">34</xref>
###xml 1789 1792 1785 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1799 1801 1795 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b035">35</xref>
###xml 1804 1807 1800 1803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1814 1816 1810 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b035">35</xref>
###xml 1819 1822 1815 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1888 1890 1884 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b036">36</xref>
###xml 1897 1900 1893 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1923 1925 1919 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b037">37</xref>
###xml 1935 1938 1931 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1948 1951 1944 1947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1981 1985 1977 1981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 1991 1994 1987 1990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 2005 2008 2001 2004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 2114 2118 2110 2114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 2266 2268 2258 2260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b038">38</xref>
###xml 229 234 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 330 335 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 339 351 <span type="species:ncbi:9606">participants</span>
###xml 636 641 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 811 816 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 945 950 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1348 1355 <span type="species:ncbi:9606">persons</span>
###xml 2096 2108 <span type="species:ncbi:9606">participants</span>
###xml 2171 2183 <span type="species:ncbi:9606">Participants</span>
Analyses were conducted using the statistical packages SAS version 9.0 (SAS Institute, ). Conformity to the genotype frequencies expected under Hardy-Weinberg equilibrium was examined for each SNP. The genetic effects of SNPs on HIV-1 infection susceptibility were assessed by comparing allelic frequencies between HIV-1 HREU and HIV-1 SC participants using the Fisher's exact test. Kaplan-Meier survival statistics and the Cox proportional hazards model were used to assess the effects of SNPs and haplotypes on the rate of progression to AIDS. We considered three separate endpoints reflecting advancing AIDS pathogenesis for SC: (1) HIV-1 infection plus a decline of CD4+ T cell counts < 200 cells/mm3 (CD4+ < 200); (2) the 1993 Centers for Disease Control and Prevention (CDC) definition of AIDS (AIDS-93): HIV-1 infection plus a CD4+ T cell count of <200/mm3 or AIDS-defining conditions [30]; (3) the 1987 CDC definition of AIDS (AIDS-87): HIV-1 infection plus AIDS-defining illness [31]. The significance of genotypic associations and RH was determined by unadjusted and adjusted Cox model regression analyses. For each SNP, we compared the minor allele genotypes to the most common genotype as a reference group. To determine if there was an additive effect of SNPs or alleles, the additive genetic model was tested by comparing survival in persons carrying two to one minor alleles to the homozygous reference group, coded as 2, 1, and 0, respectively, in the regression analysis: RH reflects effects of each copy of the allele or the haplotype. All p-values were 2-tailed. Genetic factors previously shown to affect progression to AIDS in EA and AA groups were included as confounding covariates in the adjusted Cox model analysis: CCR5 Delta32 [32]; CCR2-64I [33]; CCR5-P1 [34]; HLA-B*27 [35]; HLA-B*57 [35]; HLA-B*35Px group (including HLA-B*3502, B*3503, B*3504, and B*5301) [36]; and HLA class I homozygosity [37] for EA; HLA-B*57 and HLA class I homozygosity for AA. CCR2-64I, HLA-B*27, and HLA-B*35Px were not considered as covariates in AA due to absent or weak effects in our AA participants, and CCR5 Delta32 was not considered due to its rarity in AA. Participants were stratified by sex and by age at seroconversion: 0-20, >20-40, and >40 years [38].
###end p 67
###begin p 68
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b039">39</xref>
To evaluate which haplotype or combination of haplotypes predicted survival, the AIC generated in the Cox model was used as the model selection criterion [39]. Among models tested, the one with the smallest value of AIC was considered to be the best model.
###end p 68
###begin p 69
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b040">40</xref>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b041">41</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b042">42</xref>
To account for the multiple comparison tests performed in our analysis, we estimated the q-value measuring FDR, which is defined as the proportion of statistical tests called significant that are actually false-positive (http://faculty.washington.edu/jstorey/qvalue)[40]. The approach of computing q-values, also known as FDR adjusted p-values, was considered more powerful than the Bonferroni procedure when there is high degree of LD among the markers [41]. FDR is a recommended procedure to correct for multiple comparisons in genetic association studies [42].
###end p 69
###begin title 70
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CUL5 genotype, HIV-1 RNA, and CD4+ T cells.
###end title 70
###begin p 71
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b018">18</xref>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 474 472 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b024">24</xref>
###xml 866 867 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 448 451 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 879 884 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The repeated measurements of HIV-1 RNA levels and CD4+ T cell counts over time were modeled using the random effects linear models from HIV-1 SCs enrolled in the ALIVE study, adjusted for sex and age [18]. This model provides estimates of mean CD4+ T cell measurements over time while accounting for the correlation of repeated measurements within each individual. In all models absolute CD4+ T cell counts were square-root transformed, and plasma HIV-1RNA levels were log10 transformed to better comply with model assumptions. A likelihood ratio test was used as a test of significance. Two observation periods were used: (1) from seroconversion to the censoring date of July 31, 1997, before any impact of HAART was observed in the ALIVE cohort [24]; and (2) to increase the number of observations, from seroconversion to July 31, 2004, the last date for which CD4+ T cell and HIV-1 RNA levels were available for analysis.
###end p 71
###begin title 72
LD and haplotype structure.
###end title 72
###begin p 73
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b043">43</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b044">44</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b019">19</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b045">45</xref>
Pairwise LD was quantified using the absolute value of Lewontin's D' [43]. Absolute values of D' range from 0 for independence to 1 for complete LD between the pairs of loci. LD plots were generated utilizing Haploview version 3.11 (https://www.broad.mit.edu/mpg/haploview) [44]. A triangular matrix of D' value was used to demonstrate LD patterns within AA and EA. Haplotype blocks were defined with a default algorithm based on confidence intervals of D' [19]. Haplotypes were inferred by the expectation maximization algorithm [45].
###end p 73
###begin p 74
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b020">20</xref>
###xml 263 273 <span type="species:ncbi:9598">chimpanzee</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
To depict the relationships among inferred haplotypes and evolutionary history of the genetic variants at the CUL5 locus, a minimum mutation phylogenetic network was constructed by using NETWORK package, based on the Reduced Median (RM) network method () [20]. A chimpanzee sequence was included as an out-group and was aligned to the paralogous human sequence to infer the derived or ancestral state for each human SNP.
###end p 74
###begin title 75
EMSA.
###end title 75
###begin p 76
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b046">46</xref>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030019-b047">47</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 264 268 <span type="species:ncbi:9913">calf</span>
###xml 618 623 <span type="species:ncbi:9606">human</span>
Cell culture and EMSA were performed as described [46,47]. Freshly explanted human T lymphocytes were obtained from normal donors, purified by isocentrifugation, and activated for 72 h with 1 mg/ml phytohemaglutinin (PHA) in RPMI 1,640 medium containing 10% fetal calf serum (FCS) (Sigma, http://www.sigmaaldrich.com), 2 mM L-glutamine, and penicillin-streptomycin (50 IU/ml and 50 mg/ml, respectively). T lymphocytes were made quiescent by washing and incubating for 24 h in RPMI 1,640 medium containing 1% FCS before exposure to cytokines. Cells were then stimulated with 100 nmol/l IL-4 (PeproTech, ) or 100 nmol/l human rIL-2 (Hoffmann-La Roche, ) at 37 degreesC for 10 min. Cell pellets were frozen at -70 degreesC. The probe sequences were 5'-CAGTTGAACATaCCTTGTTAGGA-3' for SNP6 A allele and 5'-CAGTTGAACATgCCTTGTTAGGA-3' for SNP6 G allele. In cold oligonucleotide competition assay, 100-fold excess of unlabeled probe was added as a competitor. The band density was measured by the software ImageJ ().
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin title 78
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Genotyping Methods for CUL5 SNPs
###end title 78
###begin p 79
(18 KB XLS)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin title 81
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Cox Model Analysis of CUL5 Haplotypes
###end title 81
###begin p 82
(22 KB XLS)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin title 84
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Selection of the Top Models for CUL5 Haplotypes Using AIC
###end title 84
###begin p 85
(15 KB XLS)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin title 87
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
Cox Model Analysis of CUL5 SNPs in EA
###end title 87
###begin p 88
(17 KB XLS)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin title 90
Accession Numbers
###end title 90
###begin p 91
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cullin 5</italic>
###xml 105 114 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Elongin B</italic>
###xml 123 132 123 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Elongin C</italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rbx1</italic>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apobec3G</italic>
###xml 172 180 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apobec3F</italic>
###xml 195 204 195 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIV-1 Vif</italic>
###xml 195 200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Entrez Gene databank () accession numbers for the genes discussed in this paper are Cullin 5 (8065), Elongin B (6923), Elongin C (6921), Rbx1 (9978), Apobec3G (60489), Apobec3F (200316), and HIV-1 Vif (155459).
###end p 91
###begin p 92
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 36 46 <span type="species:ncbi:9598">chimpanzee</span>
The GenBank () accession number for chimpanzee CUL5 sequence is NW_113990.
###end p 92
###begin p 93
We thank Yuchun Zhou and Beth Binns-Roemer for excellent technical assistance and Xiao-Fang Yu and George Nelson for valuable discussion.
###end p 93
###begin title 94
Abbreviations
###end title 94
###begin p 95
African Americans
###end p 95
###begin p 96
adjusting
###end p 96
###begin p 97
Akaike Information Criteria
###end p 97
###begin p 98
AIDS Link to the Intravenous Experience
###end p 98
###begin p 99
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3
###end p 99
###begin p 100
cluster tagging
###end p 100
###begin p 101
European Americans
###end p 101
###begin p 102
electrophoretic mobility-shift assay
###end p 102
###begin p 103
false discovery rate
###end p 103
###begin p 104
Han Chinese
###end p 104
###begin p 105
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV type 1
###end p 105
###begin p 106
haplotype tagging
###end p 106
###begin p 107
interleukin
###end p 107
###begin p 108
linkage disequilibrium
###end p 108
###begin p 109
Multicenter AIDS Cohort Study
###end p 109
###begin p 110
Multicenter Hemophilia Cohort Study
###end p 110
###begin p 111
relative hazards
###end p 111
###begin p 112
seroconverters
###end p 112
###begin p 113
seronegatives
###end p 113
###begin p 114
single nucleotide polymorphism
###end p 114
###begin p 115
viral infectivity factor
###end p 115
###begin title 116
References
###end title 116
###begin article-title 117
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
###end article-title 118
###begin article-title 119
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
###end article-title 119
###begin article-title 120
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
###end article-title 120
###begin article-title 121
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species specific exclusion of APOBEC3G from HIV-1 virions by Vif
###end article-title 121
###begin article-title 122
DNA deamination mediates innate immunity to retroviral infection
###end article-title 122
###begin article-title 123
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
###end article-title 123
###begin article-title 124
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
###end article-title 124
###begin article-title 125
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
###end article-title 125
###begin article-title 126
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
###end article-title 126
###begin article-title 127
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
###end article-title 127
###begin article-title 128
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
###end article-title 128
###begin article-title 129
###xml 25 60 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells
###end article-title 129
###begin article-title 130
###xml 27 32 <span type="species:ncbi:9606">Human</span>
Regulation of Apobec3F and Human Immunodeficiency Virus Type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase
###end article-title 130
###begin article-title 131
Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G
###end article-title 131
###begin article-title 132
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif
###end article-title 132
###begin article-title 133
A Zinc-binding region in Vif binds Cul5 and determines Cullin selection
###end article-title 133
###begin article-title 134
APOBEC3G genetic variants and their influence on the progression to AIDS
###end article-title 134
###begin article-title 135
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 135
###begin article-title 136
###xml 27 32 <span type="species:ncbi:9606">human</span>
Mitochondrial portraits of human populations using median networks
###end article-title 136
###begin article-title 137
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex Is essential for Vif function
###end article-title 137
###begin article-title 138
###xml 45 50 <span type="species:ncbi:9606">human</span>
Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23
###end article-title 138
###begin article-title 139
VACM-1, a cullin gene family member, regulates cellular signaling
###end article-title 139
###begin article-title 140
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: Plasma viral load and CD4+ cell count
###end article-title 140
###begin article-title 141
###xml 79 107 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study
###end article-title 141
###begin article-title 142
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Long-term HIV-1 infection without immunologic progression
###end article-title 142
###begin article-title 143
Hemophilia growth and development study. Design, methods, and entry data
###end article-title 143
###begin article-title 144
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
###end article-title 144
###begin article-title 145
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
###end article-title 145
###begin article-title 146
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
###end article-title 146
###begin article-title 147
Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases
###end article-title 147
###begin article-title 148
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
###end article-title 148
###begin article-title 149
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study
###end article-title 149
###begin article-title 150
Genetic acceleration of AIDS progression by a promoter variant of CCR5
###end article-title 150
###begin article-title 151
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis
###end article-title 151
###begin article-title 152
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS
###end article-title 152
###begin article-title 153
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
###end article-title 153
###begin article-title 154
###xml 57 60 <span type="species:ncbi:9606">man</span>
Polygenic and multifactorial disease gene association in man: Lessons from AIDS
###end article-title 154
###begin article-title 155
Information theory and an extension of the maximum likelihood principle
###end article-title 155
###begin article-title 156
Statistical significance for genomewide studies
###end article-title 156
###begin article-title 157
Power and type I error rate of false discovery rate approaches in genome-wide association studies
###end article-title 157
###begin article-title 158
###xml 38 43 <span type="species:ncbi:9606">human</span>
Guidelines for association studies in human molecular genetics
###end article-title 158
###begin article-title 159
The interaction of selection and linkage. II. Optimum models
###end article-title 159
###begin article-title 160
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 160
###begin article-title 161
An E-M algorithm and testing strategy for multiple-locus haplotypes
###end article-title 161
###begin article-title 162
JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response
###end article-title 162
###begin article-title 163
Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response
###end article-title 163
###begin p 164
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. PA, SJO, and CAW conceived and designed the experiments. PA and LHW performed the experiments. PA, PD, and CAW analyzed the data. SD, JJG, JP, SB, and GDK contributed reagents/materials/analysis tools. PA and CAW wrote the paper.
###end p 164
###begin p 165
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
###xml 390 395 <span type="species:ncbi:9606">Human</span>
###xml 538 543 <span type="species:ncbi:9606">Human</span>
Funding. This project has been funded in whole or in part with federal funds from the National Cancer Institute; the National Institutes of Health (NIH), under contract N01-CO-12400; and the National Institute on Drug Abuse (NIH), under grant DA-04334. This research was also supported in part by the Intramural Research Program of the NIH, the Center for Cancer Research, and the National Human Genome Research Institute. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.
###end p 165
###begin p 166
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 166

